Home »
Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain SAN DIEGO, Feb. 19, 2020 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the U.S. Food and Drug Administration (FDA) has extended […]
Read more
Alkermes Announces U.S. Food and Drug Administration Acceptance of ALKS 3831 New Drug Application for Treatment of Schizophrenia and Bipolar I Disorder DUBLIN, Jan. 28, 2020 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) seeking approval of ALKS 3831 (olanzapine/samidorphan) for the treatment of schizophrenia and for the […]
Read more
selpercatinib Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application INDIANAPOLIS, Jan. 29, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) for selpercatinib (LOXO-292), for the treatment of patients with advanced RET fusion-positive non-small cell lung cancer (NSCLC), RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive […]
Read more
Dementia is one of the most debilitating consequences of Parkinson’s disease, a progressive neurological condition characterized by tremors, stiffness, slow movement and impaired balance. Eighty percent of people with Parkinson’s develop dementia within 20 years of the diagnosis, and patients who carry a particular variant of the gene APOE are at especially high risk. In new research, scientists at Washington University […]
Read more
When you drink, do you get depressed? Or is it the reverse: when you’re depressed, do you drink? An eight-year study of close to 1,300 teenagers by Canadian, American and German researchers appears to indicate the latter, and points to a solution: self-awareness. If people learn to recognize when they’re in a funk and deal with it, they’re less likely […]
Read more
The dentate gyrus is the “input point” for the hippocampus part of the brain. It transmits information from the short term memory to the long term. It consists of granule cells, which are especially dense in this area of the brain, and interneurons, which are linked up in the central or peripheral nervous system between several nerve cells and have […]
Read more
Having trouble paying attention? MIT neuroscientists may have a solution for you: Turn down your alpha brain waves. In a new study, the researchers found that people can enhance their attention by controlling their own alpha brain waves based on neurofeedback they receive as they perform a particular task. The study found that when subjects learned to suppress alpha waves […]
Read more
Researchers at Linköping University have developed a treatment for depression among people with cardiovascular disease. The results, recently published in JMIR Mental Health, show that cardiovascular disease patients who underwent internet-based therapy for their depression became less depressed and gained a better quality of life. It is common that cardiovascular disease (CVD) patients suffer from depression. This can lead to […]
Read more
In a new study, researchers at Boston Medical Center and Boston University have uncovered a new association between more restrictive alcohol policies and lower rates of cancer mortality. Alcohol consumption has long been related to a number of health conditions, but has recently been identified as an emerging risk factor for developing at least seven different types of cancer. Previous […]
Read more
New research indicates that social media is leading young adolescent girls and boys down a worrying path towards developing body image issues and eating disorder behaviours—even though they are smartphone savvy. The Australian research, published in the International Journal of Eating Disorders (Wiley), found platforms with a strong focus on image posting and viewing such as Instagram and Snapchat are […]
Read more